About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials LymphomaDetroit

Lymphoma Clinical Trials in Detroit

Find 239 clinical trials for lymphoma near Detroit, Michigan. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Detroit

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 239 trials

RecruitingPhase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaThis study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).NCT04234048·Scottsdale, Arizona and 9 others Active not recruitingBlinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic LeukemiaThis phase II trial studies the side effects and how well blinatumomab and combination chemotherapy or dasatinib, prednisone, and blinatumomab work in treating older patients with…NCT02143414·Birmingham, Alabama and 194 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSafety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid TumorsThis Phase 1a/1b study will evaluate the safety, tolerability and the pharmacokinetics/pharmacodynamics (PK/PD) of KT-333 in Adult patients with Relapsed or Refractory (R/R)…NCT05225584·Orange, California and 12 others

Active not recruitingStudy Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)SC291-101 is a Phase 1 study to evaluate SC291 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory biomarkers.NCT05878184·Duarte, California and 9 others

TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)This is a Phase 3 study of the PI3Kδ inhibitor Zandelisib (ME-401) in combination with rituximab, in comparison to standard immunochemotherapy (Rituximab-Bendamustine or…NCT04745832·Tucson, Arizona and 140 others

Active not recruitingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell LymphomasThis phase II/III trial tests whether it is possible to decrease the chance of high-grade B-cell lymphomas returning or getting worse by adding a new drug, venetoclax to the usual…NCT03984448·Birmingham, Alabama and 633 others

WithdrawnA Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K InhibitorThis study is designed to assess the safety, pharmacokinetics, drug-drug interactions, and determine the recommended Phase 2 doses of co administered Duvelisib and Venetoclax in…NCT02640833·Tucson, Arizona and 9 others

TerminatedRituximab in Treating Patients With Refractory or Relapsed Primary CNS LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00072449·Birmingham, Alabama and 8 others

TerminatedStudy of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)This study has 3 parts.NCT01925612·Phoenix, Arizona and 50 others

RecruitingA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaThis study is researching an experimental drug called odronextamab, referred to as study drug, when used in combination with chemotherapy.NCT06091865·Scottsdale, Arizona and 189 others

CompletedApremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyThis is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study designed to evaluate the efficacy and safety of apremilast (CC-10004) in subjects with mild to…NCT03721172·Birmingham, Alabama and 63 others

RecruitingTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerThe purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to…NCT02693535·Birmingham, Alabama and 180 others

TerminatedStudy of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)Single arm phase I/II study of ixazomib and romidepsin in relapsed/refractory PTCL. Each cycle is 28 days.NCT03547700·Chicago, Illinois and 6 others

Active not recruitingA Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaThis study will assess the efficacy and safety of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.NCT05926765·Gilbert, Arizona and 32 others

CompletedFT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)This is a phase 1 study of FT522 administered with rituximab in participants with relapsed/refractory B-cell lymphoma (R/R BCL).NCT05950334·Orlando, Florida and 6 others

Active not recruitingCombination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic LeukemiaThis phase II trial is studying the side effects of giving combination chemotherapy together with or without donor stem cell transplant and to see how well it works in treating…NCT00792948·Tucson, Arizona and 156 others

Active not recruitingEvolut™ EXPAND TAVR II Pivotal TrialObtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.NCT05149755·Birmingham, Alabama and 93 others

CompletedOpen-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's LymphomasThe objective of the study (part A) is to evaluate the efficacy and safety of BAY80-6946 in patients with indolent or aggressive Non-Hodgkin's Lymphoma, who have progressed after…NCT01660451·Birmingham, Alabama and 101 others

CompletedIbrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaThis Phase 1b/2 study is designed to assess the safety and efficacy of ibrutinib in combination with lenalidomide and rituximab in subjects with relapsed/refractory diffuse large…NCT02077166·Birmingham, Alabama and 39 others

CompletedSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantRATIONALE: Reducing the amount of drugs used to prevent transplant rejection may help a person's body kill tumor cells.NCT00002657·Mobile, Alabama and 85 others

Page 1 of 12Next

Other Conditions in Detroit

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia

Clareo Health | Lymphoma Clinical Trials in Detroit | 239 Studies